Ionis Pharmaceuticals, Inc. Revenue 2008–2025
Ionis Pharmaceuticals, Inc. annual/quarterly revenue history and growth rate from 2008 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Ionis Pharmaceuticals, Inc. revenue for the quarter ending March 31, 2026 was 246.1 M, a 86.98% increase year-over-year.
- Ionis Pharmaceuticals, Inc. revenue for the twelve months ending March 31, 2026 was 986.5 M, a 58.40% increase year-over-year.
- Ionis Pharmaceuticals, Inc. annual revenue for 2025 was 943.7 M, a 33.83% increase from 2024.
- Ionis Pharmaceuticals, Inc. annual revenue for 2024 was 705.1 M, a 10.48% decrease from 2023.
- Ionis Pharmaceuticals, Inc. annual revenue for 2023 was 787.6 M, a 34.10% increase from 2022.
- Ionis Pharmaceuticals, Inc. annual revenue for 2022 was 587.4 M.
Ionis Pharmaceuticals, Inc. (IONS) — Frequently Asked Questions
Ionis Pharmaceuticals, Inc. (IONS) is a publicly traded US company. It has a market capitalization of $11.89B. In fiscal 2025 it reported revenue of $944M and net income of -$381M. Explore IONS's stock price, financial statements, earnings history, margins and key ratios below.
What is Ionis Pharmaceuticals, Inc.'s market cap?
Ionis Pharmaceuticals, Inc. (IONS) has a market capitalization of $11.89B.
What is the IONS stock price?
IONS trades at $74.30 (+1.34% on the day).
How much revenue does Ionis Pharmaceuticals, Inc. make?
Ionis Pharmaceuticals, Inc. reported revenue of $944M in fiscal 2025.
Is IONS profitable?
In fiscal 2025, Ionis Pharmaceuticals, Inc. reported net income of -$381M.